Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1452-1459

  Yang, Jen Lin ^a,b   Chen, Jay S C ^a   Yang, Yi Fei ^a   Chen, Jyh Cheng ^a   Lin, Ching Huang ^c   Chang, Rong Seng ^d   Tsao, Po Jui ^a   Chen, Fang Pey ^a,b   Chern, Chang Ming ^b   Tsai, Tung Hu ^a   Chiu, Jen Hwey ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Acupuncture; Mice; MPTP; Neuroprotection; Neurotoxin induced; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE DERIVATIVE; IODINE 123; IOLOPRIDE; NEUROTOXIN; TYROSINE 3 MONOOXYGENASE;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; ELECTROACUPUNCTURE; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETAINED ACUPUNCTURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WESTERN BLOTTING;

ACUPUNCTURE THERAPY; ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MICE; MPTP POISONING; NEURONS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 80052779609     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.05.012     Document Type: Article

References (41)

1. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2001, 2:325-334.
2. Bjorklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 2002, 99:2344-2349.
3. Bove J., Prou D., Perier C., Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2005, 2:484-494.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Chen C.C., Chen T.F., Hwang Y.C., Wen Y.R., Chiu Y.H., Wu C.Y., Chen R.C., Tai J.J., Chen T.H., Liou H.H. Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 2009, 33:350-357.
6. Cheng Y., He G., Mu X., Zhang T., Li X., Hu J., Xu B., Du G. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci. Lett. 2008, 441:16-20.
7. Chiu J.H., Chung M.S., Cheng H.C., Yeh T.C., Hsieh J.C., Chang C.Y., Kuo W.Y., Cheng H., Ho L.T. Different central manifestations in response to electroacupuncture at analgesic and nonanalgesic acupoints in rats: a manganese-enhanced functional magnetic resonance imaging study. Can. J. Vet. Res. 2003, 67:94-101.
8. Clark J.D., Baldwin R.L., Bayne K.A., Brown M.J. Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
9. Eisenberg D.M., Kessler R.C., Foster C., Norlock F.E., Calkins D.R., Delbanco T.L. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. New Engl. J. Med. 1993, 328:246-252.
10. Eng M.L., Lyons K.E., Greene M.S., Pahwa R. Open-label trial regarding the use of acupuncture and yin tui na in Parkinson's disease outpatients: a pilot study on efficacy, tolerability, and quality of life. J. Altern. Complement. Med. 2006, 12:395-399.
11. Fahn S. Parkinson's disease: 10 years of progress, 1997-2007. Mov. Disord. 2010, 25(Suppl. 1):2-14.
12. Ferguson M.C., Nayyar T., Deutch A.Y., Ansah T.A. 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease. Neuropharmacology 2010, 59:31-36.
13. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Elsevier/Academic Press, Amsterdam, Boston.
14. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006, 24:115-124.
15. Gasser T. Mendelian forms of Parkinson's disease. Biochim. Biophys. Acta 2009, 1792:587-596.
16. Han, J.S., 2010. Acupuncture Analgesia: Areas of Consensus and Controversy, Pain.
17. Ho S.C., Chiu J.H., Yeh T.C., Hsieh J.C., Cheng H.C., Cheng H., Ho L.T. Quantification of electroacupuncture-induced neural activity by analysis of functional neural imaging with monocrystalline iron oxide nanocolloid enhancement. Am. J. Chin. Med. 2008, 36:493-504.
18. Hsieh J.C., Tu C.H., Chen F.P., Chen M.C., Yeh T.C., Cheng H.C., Wu Y.T., Liu R.S., Ho L.T. Activation of the hypothalamus characterizes the acupuncture stimulation at the analgesic point in human: a positron emission tomography study. Neurosci. Lett. 2001, 307:105-108.
19. Huot P., Parent A. Dopaminergic neurons intrinsic to the striatum. J. Neurochem. 2007, 101:1441-1447.
20. Jackson-Lewis V., Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat. Protoc. 2007, 2:141-151.
21. Jeon S., Kim Y.J., Kim S.T., Moon W., Chae Y., Kang M., Chung M.Y., Lee H., Hong M.S., Chung J.H., Joh T.H., Park H.J. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics 2008, 8:4822-4832.
22. Kato H., Kurosaki R., Oki C., Araki T. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice. Brain Res. 2004, 1030:66-73.
23. Kim S.T., Moon W., Chae Y., Kim Y.J., Lee H., Park H.J. The effect of electroacupuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum. J. Physiol. Sci. 2010, 60:27-34.
24. Kurosaki R., Muramatsu Y., Kato H., Araki T. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. Pharmacol. Biochem. Behav. 2004, 78:143-153.
25. Li H.Y., Cui L., Cui M., Tong Y.Y. Active research fields of acupuncture research: a document co-citation clustering analysis of acupuncture literature. Altern. Ther. Health Med. 2010, 16:38-45.
26. Liang X.B., Luo Y., Liu X.Y., Lu J., Li F.Q., Wang Q., Wang X.M., Han J.S. Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats. NeuroReport 2003, 14:1177-1181.
27. McKinley E.T., Baranowski T.C., Blavo D.O., Cato C., Doan T.N., Rubinstein A.L. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 2005, 141:128-137.
28. Moazzami A., Tjen A.L.S.C., Guo Z.L., Longhurst J.C. Serotonergic projection from nucleus raphe pallidus to rostral ventrolateral medulla modulates cardiovascular reflex responses during acupuncture. J. Appl. Physiol. 2010, 108:1336-1346.
29. Mounsey R.B., Teismann P. Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection. Parkinsons Dis. 2010, 2011:617472.
30. Poewe W. Treatments for Parkinson disease - past achievements and current clinical needs. Neurology 2009, 72:S65-73.
31. Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., Akram M. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 2001, 76:1265-1274.
32. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004, 318:215-224.
33. Shen E.Y., Lai Y.J. The efficacy of frequency-specific acupuncture stimulation on extracellular dopamine concentration in striatum - a rat model study. Neurosci. Lett. 2007, 415:179-184.
34. Shih L.Y., Chen L.F., Kuo W.J., Yeh T.C., Wu Y.T., Tzeng O.J., Hsieh J.C. Sensory acquisition in the cerebellum: an FMRI study of cerebrocerebellar interaction during visual duration discrimination. Cerebellum 2009, 8:116-126.
35. Shulman L.M., Wen X., Weiner W.J., Bateman D., Minagar A., Duncan R., Konefal J. Acupuncture therapy for the symptoms of Parkinson's disease. Mov. Disord. 2002, 17:799-802.
36. Stowe R., Ives N., Clarke C.E., Deane K., Wheatley K., Gray R., Handley K., Furmston A. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications. Cochrane Database Syst. Rev. 2010, CD007166.
37. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord. 2010, 25:2649-2653.
38. Wu M.T., Sheen J.M., Chuang K.H., Yang P., Chin S.L., Tsai C.Y., Chen C.J., Liao J.R., Lai P.H., Chu K.A., Pan H.B., Yang C.F. Neuronal specificity of acupuncture response: a fMRI study with electroacupuncture. Neuroimage 2002, 16:1028-1037.
39. Zesiewicz T.A., Evatt M.L. Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease. CNS Drugs 2009, 23:817-835.
40. Zhuang X., Wang L. Acupuncture treatment of Parkinson's disease - a report of 29 cases. J. Tradit. Chin. Med. 2000, 20:265-267.
41. Zou Z., Jiang X., Zhang W., Zhou Y., Ke Y., Zhang S., Xu R. Efficacy of tyrosine hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease - a rat model study. Brain Res. 2010, 1346:279-286.